GLUL Protein (Glutamine Synthetase)

Migration, Crosslink

📖

GLUL Protein (Glutamine Synthetase)

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-glul-protein

📖 Wiki Page

protein1476 wordssynced 2026-04-02

GLUL Protein (Glutamine Synthetase)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GLUL Protein (Glutamine Synthetase)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GLUL</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GLUL (Glutamine Synthetase)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GLUL" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">7 edges</a></td>
</tr>
</table>

Overview

GLUL (Glutamate-Ammonia Ligase), commonly known as Glutamine Synthetase (GS), is a crucial enzyme that catalyzes the ATP-dependent conversion of glutamate to glutamine. This enzyme plays essential roles in nitrogen metabolism, ammonia detoxification, and the glutamate-glutamine cycle that maintains neurotransmitter homeostasis in the brain[@gs_mechanism].

GLUL is particularly enriched in [astrocytes](/cell-types/astrocytes), where it performs the majority of brain glutamine synthesis, making it critical for recycling neurotransmitters (both glutamate and GABA) and detoxifying ammonia that accumulates from neural activity and metabolic processes. The enzyme is a dodecamer composed of 12 identical subunits, each approximately 49 kDa, forming a complex ring-like structure[@gs_dodecamer].

...

GLUL Protein (Glutamine Synthetase)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GLUL Protein (Glutamine Synthetase)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GLUL</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GLUL (Glutamine Synthetase)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GLUL" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">7 edges</a></td>
</tr>
</table>

Overview

GLUL (Glutamate-Ammonia Ligase), commonly known as Glutamine Synthetase (GS), is a crucial enzyme that catalyzes the ATP-dependent conversion of glutamate to glutamine. This enzyme plays essential roles in nitrogen metabolism, ammonia detoxification, and the glutamate-glutamine cycle that maintains neurotransmitter homeostasis in the brain[@gs_mechanism].

GLUL is particularly enriched in [astrocytes](/cell-types/astrocytes), where it performs the majority of brain glutamine synthesis, making it critical for recycling neurotransmitters (both glutamate and GABA) and detoxifying ammonia that accumulates from neural activity and metabolic processes. The enzyme is a dodecamer composed of 12 identical subunits, each approximately 49 kDa, forming a complex ring-like structure[@gs_dodecamer].

Dysregulation of GLUL function has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and hepatic encephalopathy, where impaired ammonia detoxification and glutamate recycling contribute to neurotoxicity.

Protein Structure and Biochemistry

Quaternary Structure

GLUL forms an impressive dodecameric assembly (12 subunits) arranged as two stacked hexameric rings:

Overall dimensions: Approximately 140 Å diameter × 100 Å height
Subunit arrangement: Two hexameric rings stacked face-to-face
Molecular weight: ~588 kDa for the complete dodecamer

Each subunit (~49 kDa) contains:

N-terminal domain (residues 1-320): Substrate binding and partial catalysis
C-terminal domain (residues 321-452): Catalytic domain
Active site: Requires Mn²⁺ or Mg²⁺ for catalysis
Inter-subunit contacts: Critical for dodecamer stability

Catalytic Mechanism

GLUL catalyzes a two-step, ATP-dependent reaction:

Step 1: Activation

Glutamate + ATP → γ-glutamyl phosphate + ADP

Step 2: Ammonia Addition

γ-Glutamyl phosphate + NH₃ → Glutamine + ADP + Pi

The reaction requires:

ATP: Energy source
Mn²⁺ or Mg²⁺: Cofactor
Glutamate substrate
Ammonia (NH₃)

Regulation

GLUL is subject to multiple regulatory mechanisms[@gs_regulation]:

Adenylation: Covalent modification that inhibits activity
Mn²⁺ dependence: Metal ion required for function
Feedback inhibition: By glutamine, its product
Phosphorylation: Post-translational control[@gs_posttranslational]

Normal Physiological Functions

Glutamate-Glutamine Cycle

The glutamate-glutamine cycle is essential for neurotransmitter homeostasis[@glutamate_glutamine_cycle]:

Neuronal Release:

Glutamate released from presynaptic neurons

Taken up by astrocytes via glutamate transporters

Astrocytic Conversion:

GLUL converts glutamate to glutamine (requires ammonia)

Glutamine transported back to neurons

Neuronal Recovery:

Neurons convert glutamine back to glutamate

GABA neurons convert to GABA

This cycle occurs continuously during normal brain function:

Mermaid diagram (expand to render)

Ammonia Detoxification

GLUL is the primary ammonia detoxification enzyme in brain[@ammonia_detoxification]:

Ammonia sources: Neural activity, metabolism, blood
Detoxification pathway: Glutamate + NH₃ → Glutamine
Critical for: Preventing ammonia neurotoxicity

Brain ammonia levels are tightly regulated:

Normal: ~0.2-0.5 mM
Elevated in liver failure → hepatic encephalopathy

Astrocyte Function

GLUL is a hallmark of astrocyte differentiation[@gs_astrocyte]:

Astrocyte-specific: Most abundant in astrocytes
Marker enzyme: Used to identify astrocytes
Metabolic hub: Central to astrocyte function

Neurotransmitter Recycling

GLUL enables continuous neurotransmitter recycling[@gaba_cycle]:

Glutamate recycling:

80% of glutamate undergoes glial recycling
Essential for maintaining glutamate pools
Prevents excitotoxicity

GABA recycling:

GABA → Glutamate → Glutamine → Glutamate cycle
GLUL critical for GABA synthesis

Role in Alzheimer's Disease

GLUL Dysfunction in AD

GLUL is significantly downregulated in AD brains[@gs_alzheimers]:

Expression Changes:

Reduced GLUL protein levels
Decreased enzyme activity
Loss of astrocytes expressing GS

Consequences:

Impaired ammonia detoxification
Reduced glutamate recycling
Contributes to excitotoxicity

Mechanism

Glutamate dysregulation:

Impaired glutamate uptake by astrocytes
Reduced conversion to glutamine
Extracellular glutamate accumulation

Excitotoxicity[@glutamate_toxicity]:

Excessive glutamate activates NMDA receptors
Calcium influx leads to neuronal death
GS dysfunction contributes to this pathway

Ammonia accumulation:

GS loss impairs ammonia detoxification
Elevated ammonia is neurotoxic
Contributes to cognitive decline

Therapeutic Implications

Targeting GLUL in AD:

Enhancing GS activity:

Gene therapy approaches
Small molecule activators
Astrocyte differentiation factors

Reducing glutamate toxicity:

Glutamate transport enhancers
Receptor antagonists
Metabolic support

Role in Parkinson's Disease

GS Alterations in PD

GLUL shows alterations in Parkinson's disease brains[@gs_parkinsons]:

Region-specific changes in substantia nigra
Astrocyte reactivity affects expression
Contributes to dopaminergic neuron vulnerability

Dopaminergic Neuron Environment

Metabolic support:

Astrocytes support dopamine neurons
GS enables glutamate recycling
Dopamine metabolism creates oxidative stress

Therapeutic targeting:

Astrocyte-based therapies
GS-enhancing approaches
Metabolic modulation

Role in Other Neurodegenerative Conditions

Hepatic Encephalopathy

GS dysfunction is central to hepatic encephalopathy[@gs_hepatic_encephalopathy]:

Ammonia accumulation:

Liver failure allows ammonia to reach brain
GS becomes overwhelmed
Elevated ammonia causes neurotoxicity

Treatment implications:

Ammonia-scavenging drugs
Liver support
GS activity enhancement

Multiple Sclerosis

GS alterations appear in MS gray matter[@ms_gray_matter]:

Loss of GS-expressing astrocytes
Demyelination affects astrocyte function
Implications for repair

Amyotrophic Lateral Sclerosis

GS changes in ALS motor neurons[@als_gs]:

Astrocyte reactivity
Glutamate metabolism alterations
Excitotoxicity contribution

Stroke and Ischemia

GS plays complex roles in ischemic injury[@stroke_gs]:

Initial activation protective
Later dysfunction contributes to damage
Therapeutic window consideration

Epilepsy

GS dysfunction may contribute to hyperexcitability[@epilepsy_gs]:

Altered glutamate cycling
Ammonia dysregulation
Therapeutic targeting

Traumatic Brain Injury

GS changes post-TBI[@traumatic_brain_injury]:

Astrocyte response
Metabolic dysfunction
Recovery phase implications

Astrocyte-Neuron Metabolic Coupling

GLUL is central to astrocyte-neuron metabolic coupling[@astrocyte_neuron_coupling]:

Glycolysis in astrocytes:

Astrocytes perform glycolysis
Lactate released to neurons
GS supports this metabolic pattern

Neurovascular coupling:

Astrocyte end-feet near blood vessels
GLUL activity affects signaling
Couples metabolism to activity

Aging and GS

GS expression declines with aging[@aging_gs]:

Reduced GS protein
Declining enzyme activity
Contributes to cognitive decline

Interventions:

Exercise enhances GS
Metabolic stimulation
Antioxidant approaches

Neuroinflammation

GLUL is affected in neuroinflammation[@neuroinflammation_gs]:

Astrocyte activation changes GS
Inflammatory cytokines regulate
Creates pathological feedback

Oxidative Stress

GS function is affected by oxidative stress[@oxidative_stress_gs]:

Reactive oxygen species inhibit
Post-translational modifications
Contributes to dysfunction

Therapeutic Strategies

Pharmacological Approaches

GS activators:

Metabolic enhancers
Gene expression promoters

GS inhibitors (for research):

Methionine sulfoximine (MSO)
Used to study GS function

Gene Therapy

Viral vector delivery
Astrocyte targeting
Expression optimization

Cell-Based Therapy

Astrocyte transplantation
Astrocyte precursors
Metabolic support cells

Biomarker Potential

GS activity may serve as biomarker:

CSF measurements
Imaging agents
Peripheral evaluation

Research Methods

Biochemical Studies

Enzyme activity assays
Immunohistochemistry
Western blotting

Imaging

MRI spectroscopy
PET ligands
Autoradiography

Genetic Studies

Transgenic models
Knockout mice
Expression studies

Summary

GLUL (Glutamine Synthetase) is a strategically important astrocyte enzyme that catalyzes glutamate to glutamine conversion, enabling ammonia detoxification and neurotransmitter recycling. The enzyme's dodecameric structure and astrocyte localization make it central to brain homeostasis. In neurodegenerative diseases including Alzheimer's and Parkinson's, GS dysfunction contributes to excitotoxicity and ammonia accumulation. The glutamate-glutamine cycle that GS enables is essential for maintaining neurotransmitter pools, and its dysfunction may be an early contributor to disease pathogenesis. Therapeutic approaches targeting GS hold promise for treating neurodegenerative conditions.

External Links

[UniProt: P15104 (GLUL Human)](https://www.uniprot.org/uniprot/P15104)
[NCBI Gene: 2595 (GLUL)](https://www.ncbi.nlm.nih.gov/gene/2595)
[RCSB PDB: 2O8V (GLUL)](https://www.rcsb.org/structure/2O8V)
[KEGG Pathway: hsa00220 (Glutamate metabolism)](https://www.genome.jp/kegg/pathway.html/hsa00220)

References

[Gill and Eisenberg, Structure of glutamine synthetase from Mycobacterium tuberculosis](https://doi.org/10.1038/87303)

[Liaw and Eisenberg, Glutamine synthetase: catalysis and mechanism](https://doi.org/10.1016/S0959-440X(94)90101-5)

[Bak et al., The glutamate-glutamine cycle in the brain](https://doi.org/10.1111/j.1471-4159.2006.04101.x)

[Martinez-Hernandez et al., Glutamine synthetase in astrocytes](https://pubmed.ncbi.nlm.nih.gov/191688/)

[Cooper and Plum, Ammonia detoxification in brain](https://doi.org/10.1152/physrev.00025.1986)

[Robinson et al., Glutamine synthetase in Alzheimer's disease brain](https://doi.org/10.1046/j.1471-4159.2001.00147.x)

[Misses et al., Glutamine synthetase alterations in Parkinson's disease](https://doi.org/10.1016/S0006-8993(99)02172-4)

[Butterworth, Glutamine synthetase in hepatic encephalopathy](https://doi.org/10.1016/S0168-8278(02)00231-5)

[Lipton and Rosenberg, Glutamate toxicity in neurodegenerative diseases](https://doi.org/10.1056/NEJM199403243401224)

[Fahien and Kde, Regulation of glutamine synthetase in brain](https://pubmed.ncbi.nlm.nih.gov/224335/)

[Pellerin and Magistretti, Astrocyte-neuron metabolic coupling](https://doi.org/10.1038/jcbfm.1994.25)

[Labow et al., Regulation of glutamine synthetase gene expression](https://doi.org/10.1159/000109853)

[Lee et al., Glutamine synthetase in neuroinflammation](https://doi.org/10.1002/glia.20684)

[Schousboe et al., GABA-glutamate cycling](https://doi.org/10.1007/s11064-010-0252-8)

[Hardy et al., Glutamine synthetase in multiple sclerosis](https://doi.org/10.1002/ana.25598)

[O'Farrell et al., Glutamine synthetase in ischemic injury](https://doi.org/10.1038/jcbfm.2008.8)

[Haidet et al., Glutamine synthetase decline in aging](https://doi.org/10.1016/j.neurobiolaging.2008.03.018)

[Rodin and Morehead, Inhibitors of glutamine synthetase](https://doi.org/10.1021/bi00176a019)

[Soules and Lienhard, Astrocyte-specific expression of glutamine synthetase](https://doi.org/10.1016/j.yexcr.2008.12.015)

[Attwell and Laughlin, Brain energy metabolism](https://doi.org/10.1097/00004647-200111000-00002)

[Vissing et al., Post-translational modification of glutamine synthetase](https://doi.org/10.1074/jbc.M306865200)

[Mattson et al., Amyloid-β and glutamate excitotoxicity](https://doi.org/10.1002/jnr.490320403)

[Yoo et al., mTOR regulation of glutamine synthetase](https://doi.org/10.1007/s10571-010-9601-1)

[Kimelberg et al., Oxidative stress and glutamine synthetase](https://doi.org/10.1007/s11064-010-0260-2)

[Rothman et al., Cerebral ammonia metabolism](https://doi.org/10.1002/ana.10322)

[Albrecht and Norenberg, Glutamine as a neurotoxin](https://doi.org/10.1016/j.tins.2006.07.006)

[Lee et al., Glutamine synthetase at the blood-brain barrier](https://doi.org/10.1111/j.1471-4159.2008.05256.x)

[van der Hel et al., Glutamine synthetase in epilepsy](https://doi.org/10.1093/brain/awh249)

[Fiske et al., Glutamine synthetase in traumatic brain injury](https://doi.org/10.1089/neu.2014.3678)

[Barbeito et al., Glutamine synthetase in ALS](https://doi.org/10.1016/j.brainresrev.2003.10.002)

📖 View canonical wiki page →

Related Entities

GLULPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-glul-protein
kg_node_id	GLULPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-cf6a1d3ce4cf
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-glul-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GLUL Protein (Glutamine Synthetase)

GLUL Protein (Glutamine Synthetase)

Overview

GLUL Protein (Glutamine Synthetase)

Overview

Protein Structure and Biochemistry

Quaternary Structure

Catalytic Mechanism

Regulation

Normal Physiological Functions

Glutamate-Glutamine Cycle

Ammonia Detoxification

Astrocyte Function

Neurotransmitter Recycling

Role in Alzheimer's Disease

GLUL Dysfunction in AD

Mechanism

Therapeutic Implications

Role in Parkinson's Disease

GS Alterations in PD

Dopaminergic Neuron Environment

Role in Other Neurodegenerative Conditions

Hepatic Encephalopathy

Multiple Sclerosis

Amyotrophic Lateral Sclerosis

Stroke and Ischemia

Epilepsy

Traumatic Brain Injury

Astrocyte-Neuron Metabolic Coupling

Aging and GS

Neuroinflammation

Oxidative Stress

Therapeutic Strategies

Pharmacological Approaches

Gene Therapy

Cell-Based Therapy

Biomarker Potential

Research Methods

Biochemical Studies

Imaging

Genetic Studies

Summary

See Also

External Links

References

💬 Discussion